Radiographic features and prognosis of early- and late-onset non-small cell lung cancer immune checkpoint inhibitor-related pneumonitis
Abstract Background Immunotherapy is becoming a standard of care for non-small cell lung cancer (NSCLC). Checkpoint inhibitor-associated pneumonia (CIP) is a rare and potentially life-threatening event that can occur at any time during tumor immunotherapy. However, there may be differences in the ra...
Main Authors: | Aiben Huang, Yang Xu, Xuelei Zang, Chongchong Wu, Jie Gao, Xiaoli Sun, Mei Xie, Xidong Ma, Hui Deng, Jialin Song, Fangping Ren, Li Pang, Jin Qian, Zhaofeng Yu, Shiyu Wan, Yuanyuan Chen, Lei Pan, Guanglei Zhuang, Sanhong Liu, Xinying Xue |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-05-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-021-08353-y |
Similar Items
-
Spatial distribution of immune checkpoint proteins in histological subtypes of lung adenocarcinoma
by: Sarah Müller, et al.
Published: (2021-06-01) -
Achievements and futures of immune checkpoint inhibitors in non-small cell lung cancer
by: Zhenbin Qiu, et al.
Published: (2019-08-01) -
Risk of Developing Checkpoint Immune Pneumonitis and Its Effect on Overall Survival in Non-small Cell Lung Cancer Patients Previously Treated With Radiotherapy
by: Feliciano Barrón, et al.
Published: (2020-09-01) -
Acute-Onset Pneumonitis while Administering the First Dose of Durvalumab
by: Erwin H.J. Tonk, et al.
Published: (2019-08-01) -
Clinical diagnosis and treatment of immune checkpoint inhibitor‐associated pneumonitis
by: Hanping Wang, et al.
Published: (2020-01-01)